Toll-like receptor polymorphisms compromise the inflammatory response against bacterial antigen translocation in cirrhosis.

PubWeight™: 0.75‹?›

🔗 View Article (PMID 28418003)

Published in Sci Rep on April 18, 2017

Authors

Paula Piñero1, Oriol Juanola1, Esther Caparrós2, Pedro Zapater3,4, Paula Giménez4, José M González-Navajas1,4, José Such5, Rubén Francés1,2,4

Author Affiliations

1: Instituto de Investigación Sanitaria y Biomédica de Alicante (ISABIAL-Fundación FISABIO), Alicante, Spain.
2: Dpto. Medicina Clínica, Universidad Miguel Hernández, San Juan, Spain.
3: Servicio de Farmacología Clínica, Hospital General Universitario de Alicante, Alicante, Spain.
4: CIBERehd, Instituto de Salud Carlos III, Madrid, Spain.
5: Digestive Disease Institute, Cleveland Clinic Abu Dhabi, UAE.

Articles cited by this

A Toll-like receptor recognizes bacterial DNA. Nature (2000) 26.34

A global reference for human genetic variation. Nature (2015) 12.85

Toll-like receptors in the induction of the innate immune response. Nature (2000) 12.23

TLR4 mutations are associated with endotoxin hyporesponsiveness in humans. Nat Genet (2000) 8.79

Inferences, questions and possibilities in Toll-like receptor signalling. Nature (2004) 7.57

Structural basis for signal transduction by the Toll/interleukin-1 receptor domains. Nature (2000) 4.36

Tlr4: central component of the sole mammalian LPS sensor. Curr Opin Immunol (2000) 4.32

Cutting edge: endotoxin tolerance in mouse peritoneal macrophages correlates with down-regulation of surface toll-like receptor 4 expression. J Immunol (2000) 4.10

Toll-like receptors as targets in chronic liver diseases. Gut (2009) 2.29

Serum and ascitic fluid bacterial DNA: a new independent prognostic factor in noninfected patients with cirrhosis. Hepatology (2008) 1.96

Intracellular cytokine expression in peritoneal monocyte/macrophages obtained from patients with cirrhosis and presence of bacterial DNA. Eur J Gastroenterol Hepatol (2005) 1.93

Increased lipopolysaccharide binding protein in cirrhotic patients with marked immune and hemodynamic derangement. Hepatology (2003) 1.91

Analysis of TLR4 polymorphic variants: new insights into TLR4/MD-2/CD14 stoichiometry, structure, and signaling. J Immunol (2006) 1.88

Toll-like receptor (TLR) 2 promoter and intron 2 polymorphisms are associated with increased risk for spontaneous bacterial peritonitis in liver cirrhosis. J Hepatol (2011) 1.62

Association of TLR4 polymorphisms with symptomatic respiratory syncytial virus infection in high-risk infants and young children. J Immunol (2007) 1.61

Metabolism and excretion of nitric oxide in humans. An experimental and clinical study. Circ Res (1993) 1.53

Presence of bacterial-DNA in cirrhosis identifies a subgroup of patients with marked inflammatory response not related to endotoxin. J Hepatol (2007) 1.51

Genetic variations of Toll-like receptor 9 predispose to systemic lupus erythematosus in Japanese population. Ann Rheum Dis (2007) 1.49

The Asp299Gly polymorphism alters TLR4 signaling by interfering with recruitment of MyD88 and TRIF. J Immunol (2012) 1.31

A sequential study of serum bacterial DNA in patients with advanced cirrhosis and ascites. Hepatology (2004) 1.29

Bacterial DNA in patients with cirrhosis and noninfected ascites mimics the soluble immune response established in patients with spontaneous bacterial peritonitis. Hepatology (2008) 1.27

Bacterial DNA activates cell mediated immune response and nitric oxide overproduction in peritoneal macrophages from patients with cirrhosis and ascites. Gut (2004) 1.18

Polymorphisms of the Toll-like receptors and human disease. Clin Infect Dis (2005) 1.06

R753Q polymorphism inhibits Toll-like receptor (TLR) 2 tyrosine phosphorylation, dimerization with TLR6, and recruitment of myeloid differentiation primary response protein 88. J Biol Chem (2012) 1.04

Toll-like receptor 2 (P631H) mutant impairs membrane internalization and is a dominant negative allele. Scand J Immunol (2010) 1.04

Serum lipopolysaccharide-binding protein prediction of severe bacterial infection in cirrhotic patients with ascites. Lancet (2004) 0.95

Toll-like receptor polymorphisms, inflammatory and infectious diseases, allergies, and cancer. J Interferon Cytokine Res (2013) 0.93

Toll-like receptor 4 D299G polymorphism and the incidence of infections in cirrhotic patients. Aliment Pharmacol Ther (2010) 0.87

Translocation of bacterial DNA from Gram-positive microorganisms is associated with a species-specific inflammatory response in serum and ascitic fluid of patients with cirrhosis. Clin Exp Immunol (2007) 0.86

Lipopolysaccharide-induced immune responses in relation to the TLR4(Asp299Gly) gene polymorphism. Clin Vaccine Immunol (2008) 0.81

Grade of soluble inflammatory response is mainly affected by circulating bacterial DNA concentrations in cirrhosis. Liver Int (2016) 0.77